Difference between revisions of "Labetalol"
From WikiAnesthesia
(Created page with "{{Infobox drug reference | trade_names = | drug_class = | drug_class_color = | uses = | contraindications = | routes = | dosage = }} Provide a brief summary of this dr...") |
Chris Rishel (talk | contribs) m (Added embedded dosage calculation) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox drug reference | {{Infobox drug reference | ||
| trade_names = | | trade_names = | ||
| drug_class = | | image_file = Labetalol.svg | ||
| drug_class_color = | | drug_class = Beta blocker | ||
| drug_class_color = cardiovascular_antagonist | |||
| uses = | | uses = | ||
| contraindications = | | contraindications = | ||
| routes = | | routes = IV, PO | ||
| dosage = | | dosage = | ||
| dosage_calculation = labetalol | |||
| mechanism = Nonselective beta antagonism | |||
| adverse_effects = | |||
| time_onset = | |||
| duration = | |||
| metabolism = | |||
| halflife_redistribution = | |||
| halflife_elimination = | |||
| clearance = | |||
| protein_binding = | |||
}} | }} | ||
| Line 36: | Line 47: | ||
[[Category:Drug reference]] | [[Category:Drug reference]] | ||
[[Category:Adrenergic receptor modulators]] | |||
[[Category:Beta blockers]] | |||
[[Category:Chronotropes]] | |||
[[Category:Negative chronotropes]] | |||
Latest revision as of 00:58, 30 March 2022
Labetalol
 | |
| Clinical data | |
| Drug class |
Beta blocker |
|---|---|
| Routes of administration |
IV, PO |
| Dosage | |
|
Double dose q5-10m until desired effect achieved.
|
|
| Pharmacodynamics | |
| Mechanism of action |
Nonselective beta antagonism |
| Pharmacokinetics | |
| Physical and chemical data | |
| Article quality | |
| Editor rating | |
| User likes | 0 |
Provide a brief summary of this drug here.
Uses
Contraindications
Absolute contraindications
Precautions
Pharmacology
Pharmacodynamics
Mechanism of action
Adverse effects
Pharmacokinetics
Chemistry and formulation
History
References
Top contributors: Olivia Sutton and Chris Rishel